Clinical Trial Update: Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating perifosine in patients with recurrent, refractory, locally advanced, or metastatic breast cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED